Annovis Bio Inc

NYSE:ANVS

18.01

+4.41 (+32.43%)

7:58:40 PM EDT: $17.90 -0.11 (-0.61%)

Annovis Bio Inc Stock, NYSE:ANVS

101 Lindenwood Drive, Suite 225, Malvern, Pennsylvania 19355

United States of America

Phone: +1.484.875.3192

Number of Employees: 6

http://www.annovisbio.com

Description

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.